The Diversity in Early Development Clinical Trials Research Grants Program is supporting four teams to increase diversity among participants in Phase 1 and Phase 2 cancer clinical trials. The objective is to increase accessibility for patients of all racial and ethnic backgrounds and/or medically underserved locations
to equally participate in studies.
Each Team is bringing together key stakeholders that are deeply connected to the impacted communities, integrating social/ behavioral determinants of health, community engagement and outreach with cancer biology, prevention, and treatment, and realizing the ideal of health equity.